National Institute on Alcohol Abuse and Alcoholism (NIAAA): all 102 studies

Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)RecruitingNCT07559500Phase 1
• Human Laboratory Study of Apremilast for Alcohol Use DisorderRecruitingNCT07325266Phase 2
• Tirzepatide in MetALDRecruitingNCT07046819Phase 2
• Role of Metal Ion Transporter ZIP8 in Alcohol-Related BehaviorsRecruitingNCT06819189Phase 1
• Suvorexant for Alcohol Use Disorder (AUD): Neural MechanismsRecruitingNCT06484075Phase 1/2
• Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use DisorderRecruitingNCT06269627Phase 4
• Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)RecruitingNCT05677321
• Addictions Neuroclinical Assessment (ANA)Enrolling by invitationNCT04946851
• Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy DrinkersRecruitingNCT04781322Phase 1
• Mechanisms Underlying Individual Variations of Taste and Smell in ObesityRecruitingNCT04714892
• COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History StudyRecruitingNCT04391816
• Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)RecruitingNCT03407079Phase 2
• Nicotinic Receptor Genetic Variation and Alcohol RewardRecruitingNCT03294460Phase 1
• Development Of Neuroimaging Methods To Assess The Neurobiology Of AddictionRecruitingNCT02535702Not applicable
• NIAAA Natural History ProtocolRecruitingNCT02231840
• Human Laboratory Study of ASP8062 for Alcohol Use DisorderCompletedNCT05096117Phase 2Results posted
• HLAB-002 of ANS-6637 for Alcohol Use DisorderTerminatedNCT03970109Phase 2Results posted
• Intranasal Oxytocin for the Treatment of Alcohol Use DisorderCompletedNCT03878316Phase 2Results posted
• Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRICompletedNCT03326245Phase 1Results posted
• Ketogenic Diet (KD) in AlcoholismCompletedNCT03255031Not applicableResults posted
• Human Laboratory Study of Varenicline for Alcohol Use DisorderCompletedNCT03035708Phase 1/2Results posted
• A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part IITerminatedNCT02707055Phase 2Results posted
• HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use DisorderCompletedNCT02252536Phase 2Results posted
• Genetic Effects on Dopamine Response to an OpiateCompletedNCT01878006Phase 2Results posted
• Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy DrinkersCompletedNCT01779024Phase 2Results posted
• Baclofen for Treating Anxiety and AlcoholismCompletedNCT01751386Phase 2Results posted
• Role of Proinflammatory Signaling in Alcohol CravingTerminatedNCT01631630Phase 2Results posted
• ABT-436 for Alcohol DependenceCompletedNCT01613014Phase 2Results posted
• Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body CompositionCompletedNCT01251887Not applicableResults posted
• Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^CompletedNCT01227980Phase 2Results posted
• CRF1 Antagonist GSK561679 in AlcoholismCompletedNCT01187511Phase 2Results posted
• Varenicline for Alcohol DependenceCompletedNCT01146613Phase 2Results posted
• Levetiracetam XR in Very Heavy DrinkersCompletedNCT00970814Phase 2Results posted
• The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients With PTSDCompletedNCT00896038Phase 2Results posted
• Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified AlcoholicsCompletedNCT00605904Phase 2Results posted
• Study of the Effectiveness of Quetiapine for the Treatment of Alcohol DependencyCompletedNCT00498628Phase 2Results posted
• Effect of LY686017 on Alcohol CravingCompletedNCT00310427Phase 2Results posted
• Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk BehaviorsCompletedNCT04360018Phase 1
• Brain Dopaminergic Signaling in Opioid Use DisordersCompletedNCT03190954Early Phase 1
• Oxytocin in Alcohol Use DisorderWithdrawnNCT02711189Phase 1
• Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy PeopleCompletedNCT02669225Early Phase 1
• Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene VariationCompletedNCT02639273Phase 1
• Study of Structural ImagingCompletedNCT02564991
• Epi-Genetic Modulators of Fear Extinction in Alcohol DependenceCompletedNCT02438969
• Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and WakefulnessCompletedNCT02311374Early Phase 1
• Brain Inflammation and Function in AlcoholismCompletedNCT02233868Early Phase 1
• Dopamine Rhythms in Health and AddictionWithdrawnNCT02233829Early Phase 1
• Reliability of the Human Brain ConnectomeCompletedNCT02193425Early Phase 1
• Traits Associated With Early Life Stress Among Treatment-Seeking AlcoholicsWithdrawnNCT02181608
• Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) TrialTerminatedNCT02156089Phase 2
• Neural Substrates of Approach-Avoidance ConflictCompletedNCT02119624
• Characterization Imaging Instruments in Alcoholics and Non-AlcoholicsCompletedNCT02108080
• Behavioral and Functional Task Development, Implementation, and TestingCompletedNCT02108054Not applicable
• A Novel Compound for Alcoholism TreatmentCompletedNCT02039349Phase 1
• Measuring Effects of Alcohol on Brain ChemistryTerminatedNCT01492933
• Genetics of the Acute Response to Alcohol in Social DrinkersTerminatedNCT01375556Phase 1
• National Epidemiologic Survey on Alcohol and Related Conditions-IIICompletedNCT01273220
• Aripiprazole and Topiramate on Free-Choice Alcohol UseCompletedNCT00884884Phase 2/3
• Alcohol Early Intervention for FreshmenStatus unknownNCT00852033Not applicable
• Computer-Assisted Self-Administration of EthanolCompletedNCT00713492Phase 1
• The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol InfusionCompletedNCT00667771Early Phase 1
• Neurosteroids and Acute Alcohol Intoxication in HumansStatus unknownNCT00608686Phase 1
• Psychoeducation for Hepatitis and Alcohol BehaviorsCompletedNCT00598416Not applicable
• Aftercare for Adolescents Treated for Alcohol Abuse and DependenceCompletedNCT00561041Phase 2
• Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance UseStatus unknownNCT00547963Phase 2/3
• Medication and Counseling for Controlled Drinking (Project SMART)CompletedNCT00444418Phase 3
• OPRM1 A118G SNP, Alcohol Response, and Striatal DopamineCompletedNCT00401999
• Healthy Living as You AgeCompletedNCT00379093Phase 2
• Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In VivoCompletedNCT00342303
• Blood Sample Donations to Study the Role of Genes in PainCompletedNCT00341367
• Individualized Treatment Program for Alcohol ProblemsCompletedNCT00298792Phase 1
• Treatment of Patients With Alcoholism and Attention Deficit DisorderCompletedNCT00261872Phase 4
• Hangover, Congeners, Sleep and Occupational PerformanceCompletedNCT00247585Phase 2
• Stepped Care for Mandated College StudentsCompletedNCT00247182Phase 1
• A Placebo-Controlled Trial of Memantine for Alcohol DependenceCompletedNCT00246415Phase 2
• Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus LorazepamCompletedNCT00229125Phase 2
• Project RAP: Reaching Adolescents for PreventionStatus unknownNCT00183157Phase 2
• Alcoholism Assessment and TreatmentCompletedNCT00106093
• Rimonabant to Reduce Alcohol ConsumptionCompletedNCT00075205Phase 2
• PET Imaging of DHA MetabolismCompletedNCT00074503
• The Effect of Ethanol on Brain ActivityCompletedNCT00074360
• Influence of Age and Sex on Alcohol Metabolism and Acute ResponsesCompletedNCT00070577
• Role of Dopamine in Response to AlcoholCompletedNCT00050219
• Brain Function in Response to Motivational StimuliCompletedNCT00047866
• Bupropion as a Smoking Cessation Aid in AlcoholicsCompletedNCT00044434Phase 4
• Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)CompletedNCT00027079Phase 2
• Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under StressCompletedNCT00014027Phase 1
• Effect of Fluoxetine (Prozac) on Domestic ViolenceCompletedNCT00011765Phase 2
• Serotonin in AlcoholismCompletedNCT00011752
• Comparing Gabapentin and Lorazepam for Treating Alcohol WithdrawalCompletedNCT00011297Phase 2
• Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)CompletedNCT00006204Phase 4
• The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and NonalcoholicsCompletedNCT00001675
• Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedNCT00001673
• Sertraline and Cognitive Therapy in Depressed AlcoholicsCompletedNCT00000458Phase 2
• Naltrexone Treatment of Alcohol DependenceCompletedNCT00000452Phase 4
• Behavior and Naltrexone Treatment for AlcoholicsCompletedNCT00000449Phase 4
• Drug Treatment for Alcoholics With Post-Traumatic Stress DisorderCompletedNCT00000446Phase 2
• Use of Naltrexone in a Clinical SettingCompletedNCT00000445Phase 4
• Ondansetron Treatment for AlcoholismCompletedNCT00000443Phase 2
• Drug Therapy for Alcohol DetoxificationCompletedNCT00000441Phase 4

← National Institute on Alcohol Abuse and Alcoholism (NIAAA) overview and focus areas